Twenty-one years after the start of the George Washington University (GW) Medical Faculty Associates’ (MFA) Mobile Mammography Program, supporters gathered at the Embassy of France in Washington, D.C., on Oct. 17 for the Blush Luncheon to toast a new mammovan and the future of the program.
More than 30 years ago in Lima, Peru, Elmer Huerta, MD, MPH, newly established director of the Cancer Preventorium Clinic at the George Washington University (GW) Cancer Center and clinical professor of medicine at the GW School of Medicine and Health Sciences (SMHS), entered the emergency room to find a patient in need of his help.
When planning their wedding, Yuan James Rao, MD, director of brachytherapy at the George Washington University (GW) Cancer Center and assistant professor of radiology at the GW School of Medicine and Health Sciences (SMHS), and Destie Provenzano, a PhD candidate in the GW Department of Biomedical Engineering, had no idea the day would land amid a global health crisis.
A diagnosis of breast cancer is a scary moment in any person’s life, and going through treatment can be difficult on both the mind and the body, but at the George Washington University (GW) Cancer Center, the journey can be made a little easier thanks to support from current and former patients and community members.
Through a patient and community member-supported patient assistance fund, the GW Breast Care Center is able to offer financial assistance and a monthly complementary care clinic for patients. The fund was started in 2007 by GW patient LuAnn Dean.
At the George Washington University (GW) Cancer Center, listening to the needs of the community is a vital responsibility. That’s why in the city that has among the highest percentages of individuals who identify as lesbian, gay, bisexual, transgender, queer, or intersex (LGBTQI), the GW Cancer Center is ensuring its residents are always heard.
Innumerable questions and concerns loom after a cancer diagnosis. Among them: Should I participate in a clinical trial, or should I stick with the standard of care? Here's an inside look at the clinical trials process.
In June 2018, before a room full of oncology experts, Robert Siegel, MD ’77, associate center director for education, training, and network development at the GW Cancer Center, described a new treatment developed for patients suffering from oropharyngeal cancer.
The future of cancer research, in the opinion of Katherine Chiappinelli, PhD, of the GW School of Medicine and Health Sciences, revolves around combining immunotherapy with other treatments.